Hikma Pharmaceuticals PLC (LON:HIK – Get Free Report)’s stock price passed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 1,922.34 ($24.05) and traded as high as GBX 2,002.90 ($25.06). Hikma Pharmaceuticals shares last traded at GBX 2,002.90 ($25.06), with a volume of 103,513 shares trading hands.
Hikma Pharmaceuticals Price Performance
The business’s 50-day simple moving average is GBX 1,914.86 and its two-hundred day simple moving average is GBX 1,922.34. The stock has a market cap of £4.44 billion, a price-to-earnings ratio of 3,081.38, a price-to-earnings-growth ratio of 2.38 and a beta of 0.41. The company has a debt-to-equity ratio of 55.48, a current ratio of 1.66 and a quick ratio of 1.27.
About Hikma Pharmaceuticals
At Hikma we help put better health within reach, every day. By creating high-quality medicines and making them accessible to the people who need them, we help to shape a healthier world that enriches all our communities. We help deliver this by living our culture, delivering our strategy, and acting responsibly.
Featured Articles
- Five stocks we like better than Hikma Pharmaceuticals
- What is a Special Dividend?
- Work and Play: Investing in the Rise of Bleisure Travel
- Election Stocks: How Elections Affect the Stock Market
- Top Dividend Stocks to Buy Now as Bond Yields Could Lower
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- SAP: AI Tailwinds Accelerating Enterprise Cloud Business
Receive News & Ratings for Hikma Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hikma Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
